Huatai Biopharm Inc. is the US FDA cGMP approved leading manufacturer and supplier of ultra-pure and highly concentrated Omega-3 EPA/DHA Fatty Acids for pharmaceutical (Active Pharmaceutical Ingredient-API) and nutraceutical purpose. Huatai Biopharm locates in Deyang, Sichuan, P.R. China. From it's foundation in 1998, Huatai Biopharm dedicates to research and innovation of purification science and technologies to produce ultra-pure and highly concentrated Omega-3 EPA/DHA fatty acids. The unique and proprietary purification technologies enable the parameters for Oxidation and Environmental Pollutants approach to the most stringent quality standards,which exceed all known standards such as in GOED, EU Pharmacopoeia (EP), US Pharmacopoeia (USP) Monograph.
Year Established: 1998
Total Assets(USD): choose not to disclose
Total Number of Staff: less than 10 person
Annual Turnover(USD) : choose not to disclose
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect